Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Shenzhen
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Shenzhen Hepalink Pharmaceutical Co Ltd

+ Add to Watchlist

002399:CH

29.290 CNY 0.200 0.68%

As of 02:00:22 ET on 03/05/2015.

Snapshot for Shenzhen Hepalink Pharmaceutical Co Ltd (002399)

Open: 29.490 Day's Range: 29.120 - 30.090 Volume: 6,573,305
Previous Close: 29.490 52wk Range: 18.110 - 30.700 1-Yr Rtn: +31.77%

Stock Chart for 002399

No chart data available.
  • 002399:CH 29.290
  • 1D
  • 1M
  • 1Y
29.490
Interactive 002399 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 002399

Current P/E Ratio (ttm) 94.1819
Estimated P/E(12/2014) 73.2250
Relative P/E vs. SZASHR 2.2016
Earnings Per Share (CNY) (ttm) 0.3110
Est. EPS (CNY) (12/2014) 0.4000
Est. PEG Ratio -
Market Cap (M CNY) 23,437.86
Shares Outstanding (M) 800.20
30 Day Average Volume 4,399,365
Price/Book (mrq) 2.8811
Price/Sale (ttm) 13.7338
Dividend Indicated Gross Yield 1.02%
Cash Dividend (CNY) 0.3000
Dividend Ex-Date 06/09/2014
5 Year Dividend Growth -
Next Earnings Announcement 04/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 002399

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 002399

Shenzhen Hepalink Pharmaceutical Co., Ltd researches, produces and sells heparin pharmaceuticals products. The Company's products include heparin sodium active pharmaceutical ingredient.

Li LiChairmanShan YuPresident
Li TanVice PresidentYan ChenguangVice President
More Company Profile & Key Executives for 002399

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil